Original ArticlesmiR-1236 regulates hypoxia-induced epithelial–mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3
Introduction
Intratumoral hypoxia is one of the crucial events that mediate cancer metastasis [1], [2]. Hypoxia induces epithelial–mesenchymal transition (EMT), a critical process involved in development and tumor progression [3], [4]. EMT is a process whereby epithelial cell layers lose polarity and cell–cell contact and undergo a dramatic remodeling of cytoskeleton to increase cell migration and invasion activity [3], [4]. EMT is usually mediated by transcriptional regulators, including Snail, Slug, Twist1, ZEB1, ZEB2, etc [3], [4], [5]. Interestingly, these EMT transcriptional regulators are also regulated by hypoxia/hypoxia-inducible factor 1α (HIF-1α) [5], [6].
Hypoxia-induced EMT can occur through various epigenetic mechanisms [7], [8]. One of the important mechanisms is through the interplay between HDAC3 and WDR5 to regulate EMT marker gene (i.e. E-cadherin, vimentin, etc) expression [9]. HDAC3 removes the acetyl group of histone 3 lysine 4 (H3K4Ac) to facilitate the repression of epithelial gene and activation of mesenchymal gene expression [8], [9]. Knockdown of HDAC3 abolishes hypoxia-induced EMT marker gene regulation [8], [9]. HDAC3 obviously plays an important role in hypoxia-induced EMT. SUMO-specific protease 1 (SENP1) reverses the sumolyation of HIF-1α to prevent its ubiquitination and degradation [10]. SENP1 plays a critical role in the stabilization of HIF-1α [10].
MicroRNAs (miRNAs) are 18–24 nucleotide noncoding RNA molecules that regulate gene expression at various levels [11]. MiRNAs may have oncogene or tumor suppressor property depending on their targets [11], [12]. Various miRNAs have been shown to be involved in EMT [12]. Hypoxia/HIF-1α regulates various miRNAs to mediate tumor progression, induce drug resistance, and regulate tumor cell lysis by cytotoxic T cells [13], [14], [15], [16].
MicroRNA miR-1236 is an intronic miRNA (102 bp in size) that is located in chromosome 6p. MiR-1236-3p is the major form and there is no other family member (GeneCards and miRBase database). MiR-1236 and Negative Elongation Factor E (NELFE) share the same promoter and miR-1236 co-expresses with NELFE [17], [18]. MiR-1236 is found only in human, Pan troglodytes and Pongo pygmaeus (GeneCards and miRBase database). MicroRNA miR-1236 has been shown to repress VEGFR-3, α-fetoprotein, VprBP, RORγ, p21 promoter, and ZEB1 to inhibit inflammatory lymphangiogenesis, PI3K/Akt pathway, HIV-1 infection, ulcerative colitis, cell proliferation, or cell migration/invasion, respectively [19], [20], [21], [22], [23], [24]. MiR-1236 has been shown to be induced by IL-1β [19]. MiRNAs that regulate HDAC3 or SENP1 have been identified [25], [26]. However, whether a single miRNA can simultaneously regulate SENP1 and HDAC3 remains to be discovered.
In this study, we show that miR-1236 regulates EMT and cancer cell migration and invasion by simultaneously repressing HDAC3 and SENP1 expression. Due to the ability of SENP1 to stabilize HIF-1α, repression of miR-1236 during hypoxia causes abolishment of SENP1 inhibition and leads to increased HIF-1α levels. We also show that Twist1 represses the expression of miR-1236 by direct binding to the promoter region of miR-1236. We show that miR-1236 expression is repressed by Twist1 under hypoxia, which activates the levels of HDAC3 and SENP1 and contributes to EMT and cancer metastasis induced by hypoxia.
Section snippets
Cell lines and oxygen deprivation
Human breast cancer (MCF7), lung cancer (H1299), head and neck cancer (SAS) and embryonic kidney (293T) cell lines have been described previously [6], [9]. The H1299-miR-1236 and MCF7-miR-1236 cell lines were generated by transfecting the pMcherry-miR-1236 plasmid into H1299 and MCF7 cells followed by puromycin (2 µg/ml) selection. The H1299-Cont. and MCF7-Cont. cell lines were generated by transfecting the pmR-mcherry plasmid into H1299 and MCF7 cells followed by puromycin (2 µg/ml) selection.
Identification of miR-1236 that regulates HDAC3 through a bioinformatics approach
HDAC3 has been shown to play a critical role in hypoxia-mediated epithelial–mesenchymal transition [9]. However, the miRNAs that can regulate HDAC3 remain unknown. In order to identify the miRNAs that regulate HDAC3 and further investigate the functions of the HDAC3-regulating miRNAs, we first used the prediction programs “Targetscan” and “miRanda” to search for the miRNAs that possibly target HDAC3. Through the intersection of Targetscan and miRanda results, eight miRNAs that possibly target
Discussion
Hypoxia-induced epithelial–mesenchymal transition (EMT) plays a crucial role in cancer metastasis induced by intratumoral hypoxia [2], [6], [9]. Epigenetic mechanisms that regulate hypoxia-induced EMT have been reviewed [7], [8], [9]. However, microRNAs that could regulate hypoxia-induced EMT are largely unknown except a few hypoxia-induced microRNAs that were shown to mediate cancer metastasis, induce drug resistance, and regulate tumor cells lysis by cytotoxic T cells [13], [14], [15], [16].
Funding
This work was supported in part to K.J.W. by Ministry of Science and Technology Summit grant (MOST 104-2745-B-039-001-ASP), Center of Excellence for Cancer Research at Taipei Veterans General Hospital (MOHW105-TDU-B-211-134-003), and National Health Research Institutes (NHRI-EX104-10230SI).
Authors' contributions
KJW conceived and designed the experiments. SYC performed the experiments. KJW, SCT, and THC analyzed the data and provided input to the project. KJW wrote the manuscript.
Conflict of interest
All of the authors of this paper declare that they have no conflict of interest.
References (31)
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Trends Pharmacol. Sci
(2012)- et al.
Epithelial-mesenchymal transitions in development and disease
Cell
(2009) - et al.
Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition
Trends Genet
(2012) - et al.
Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition
Mol. Cell
(2011) - et al.
SUMO-specific protease 1 is essential for stabilization of HIF-1a during hypoxia
Cell
(2007) - et al.
Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation
Mol. Cell
(2009) - et al.
Targeted p21(WAF1/CIP1) activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma
Urol. Oncol
(2016) - et al.
miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs
J. Biol. Chem
(2014) - et al.
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen
Cell
(2006) - et al.
Hypoxia and hypoxia-inducible factors: master regulators of metastasis
Clin. Cancer Res
(2011)
Epithelial-mesenchymal plasticity in carcinoma metastasis
Genes Dev
TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development
Cell Cycle
Direct regulation of TWIST by HIF-1alpha promotes metastasis
Nat. Cell Biol
Epigenetic regulation of hypoxia-responsive gene expression: focusing on chromatin and DNA modifications
Int. J. Cancer
The microcosmos of cancer
Nature
Cited by (43)
MiR-1236: Key controller of tumor development and progression: Focus on the biological functions and molecular mechanisms
2023, Pathology Research and PracticemiR-589-5p Inhibits Cell Proliferation by Targeting Histone Deacetylase 3 in Triple Negative Breast Cancer
2022, Archives of Medical ResearchCitation Excerpt :MiRs have also a vital function in cell development, proliferation, differentiation, and death, through interactions with their target genes (19). Previous studies revealed that miR-1236 (20), miR-132-3p (21), miR-326 (22), and miR-193b-3p (23) target the 3′-UTR of HDAC3 mRNA. We performed an in-detailed bioinformatics analysis and found that miR-589-5p potentially targets HDAC3.
Regulatory noncoding RNAs and the major histocompatibility complex
2021, Human ImmunologyHDAC3 protects against atherosclerosis through inhibition of inflammation via the microRNA-19b/PPARγ/NF-κB axis
2021, AtherosclerosisCitation Excerpt :Moreover, HDAC3 has been found to inhibit the onset of AS by promoting endothelial cell survival [9]. In addition, numerous studies have indicated that HDAC3 is capable of regulating the expression of certain microRNAs (miRNAs) [10,11], which are small non-coding RNAs with the ability to modulate gene expression at the post-transcriptional level [12]. Studies have also shown the crucial roles of miRNAs in the initiation and progression of human diseases, acting either as oncogenes or as tumor suppressors, representing novel therapeutic agents [13].
Hypoxia-induced epithelial to mesenchymal transition in cancer
2020, Cancer LettersCitation Excerpt :Hypoxia induction of EMT required downregulation of miR-34A, and ectopic expression of miR-34A inhibited the transition process [131]. Hypoxia similarly repressed miR-1236 through a TWIST-mediated pathway, while ectopic expression of the miRNA abolished hypoxia-induced EMT [132]. Although several examples exist whereby hypoxia regulates EMT by downregulating miRNA, upregulation of miR-210 in the hypoxic niche causes suppression of E-cadherin and promotes EMT [133].